Cargando…

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

AIMS: To determine the effects of empagliflozin on blood pressure (BP) and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes mellitus (T2DM). METHODS: We conducted a post hoc analysis of data from a phase III trial in patients with T2DM and hypertension receiving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chilton, R., Tikkanen, I., Cannon, C. P., Crowe, S., Woerle, H. J., Broedl, U. C., Johansen, O. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057299/ https://www.ncbi.nlm.nih.gov/pubmed/26343814 http://dx.doi.org/10.1111/dom.12572

Ejemplares similares

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
por: Cherney, David ZI, et al.
Publicado: (2014)

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
por: Neeland, Ian J, et al.
Publicado: (2016)

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials
por: Salsali, A., et al.
Publicado: (2016)

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4‐week, randomized, placebo‐controlled trial (EASE‐1)
por: Pieber, T. R., et al.
Publicado: (2015)

Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78‐week randomized, double‐blind, placebo‐controlled trial
por: Rosenstock, J., et al.
Publicado: (2015)

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME(®) trial
por: Fitchett, David, et al.
Publicado: (2016)

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
por: Zinman, Bernard, et al.
Publicado: (2017)

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
por: Ring, Arne, et al.
Publicado: (2013)

Effect of 3-Month Therapy with Empagliflozin on Ambulatory Blood Pressure and Arterial Stiffness in Patients with Type 2 Diabetes Mellitus
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes: A 24-week, randomized, double-blind, placebo-controlled trial
por: Häring, Hans-Ulrich, et al.
Publicado: (2013)

Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin: An active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes
por: Ferrannini, Ele, et al.
Publicado: (2013)

Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control
por: Ridderstråle, Martin, et al.
Publicado: (2013)

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
por: Zinman, Bernard, et al.
Publicado: (2014)

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes
por: Perkins, Bruce A., et al.
Publicado: (2015)

Vascular stiffness and healthy arterial aging in older patients with optimal blood pressure
por: Jiticovski, Alessandra Ferreira Mendes, et al.
Publicado: (2023)

Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial
por: Roden, Michael, et al.
Publicado: (2015)

Blood Pressure-Adjusted Values of Markers of Arterial Stiffness: Three Brothers or also Others?
por: Tomiyama, Hirofumi
Publicado: (2019)

Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
por: Baron, Kyle T., et al.
Publicado: (2016)

Changes in blood pressure and arterial stiffness monitored using the cardio–ankle vascular index during hemodialysis
por: Sato, Shuji, et al.
Publicado: (2023)

Uric acid and arterial stiffness in children and adolescents: Role of insulin resistance and blood pressure
por: Genovesi, Simonetta, et al.
Publicado: (2022)

Vascular Aging and Arterial Stiffness
por: Mikael, Luana de Rezende, et al.
Publicado: (2017)

Effects of smoking cessation on central blood pressure and arterial stiffness
por: Takami, Takeshi, et al.
Publicado: (2011)

Age, Arterial Stiffness, and Components of Blood Pressure in Chinese Adults
por: Zheng, Meili, et al.
Publicado: (2014)

Relationship between arterial stiffness and circadian pattern of blood pressure
por: Park, Jin-Sun, et al.
Publicado: (2019)

Blood Pressure and Arterial Stiffness in Kenyan Adolescents With α(+)Thalassemia
por: Etyang, Anthony O., et al.
Publicado: (2017)

Central and peripheral blood pressures and arterial stiffness increase in hypoparathyroidism
por: Pamuk, Naim, et al.
Publicado: (2020)

Arterial Stiffness in Chronic Kidney Disease: The Usefulness of a Marker of Vascular Damage
por: Bellasi, Antonio, et al.
Publicado: (2011)

Restoring Blood Pressure in Hypertensive Mice Fails to Fully Reverse Vascular Stiffness
por: Steppan, Jochen, et al.
Publicado: (2020)

Evaluation of Blood Pressure Control using a New Arterial Stiffness Parameter, Cardio-ankle Vascular Index (CAVI)
por: Shirai, Kohji, et al.
Publicado: (2013)

Blood Pressure and Arterial Stiffness in Kenyan Adolescents With the Sickle Cell Trait
por: Etyang, Anthony O, et al.
Publicado: (2018)

Associations Between Blood Pressure and Arterial Stiffness With Cognition: Neuroaggression or Neuroselection?
por: Ferreira, Isabel
Publicado: (2018)

Effects of Different Antihypertensive Drug Combinations on Blood Pressure and Arterial Stiffness
por: Jatic, Zaim, et al.
Publicado: (2019)

Relationship between arterial stiffness and variability of home blood pressure monitoring
por: Park, Jin-Sun, et al.
Publicado: (2020)

Brachial and central blood pressure and arterial stiffness in adult elite athletes
por: Tomschi, Fabian, et al.
Publicado: (2021)

Harmonic Distortion of Blood Pressure Waveform as a Measure of Arterial Stiffness
por: Milkovich, Nicholas, et al.
Publicado: (2022)

Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
por: Pauklin, Priit, et al.
Publicado: (2021)

Systolic Blood Pressure Trajectories and the Progression of Arterial Stiffness in Chinese Adults
por: Liu, Run, et al.
Publicado: (2022)

Arterial stiffness and blood pressure increase in pediatric kidney transplant recipients
por: Sugianto, Rizky Indrameikha, et al.
Publicado: (2022)

Relations between white coat effect of blood pressure and arterial stiffness
por: Cao, Rong, et al.
Publicado: (2022)

Arterial Stiffness in Overweight and Obesity: Association with Sex, Age, and Blood Pressure
por: Eikås, John G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n66400u69vp1tscsvvicbvuc3a